한글목차

세계의 통 마이 그래뉼 시장 미래는 병원, 클리닉, 약국 시장의 기회에서 유망시되고 있습니다. 세계의 통 마이 그래뉼 시장은 2025-2031년 연평균 복합 성장률(CAGR) 8%를 나타낼 것으로 예측됩니다. 이 시장의 주요 촉진요인은 순환기계의 건강에 대한 tcm의 의식 증가, 순환기계의 문제가 있는 노인 인구 증가, 주요 성분의 이점을 강조하는 연구 증가입니다.

• Lucintel의 예측에서는 유형별로는 당류가 예측 기간 중에 높은 성장을 이룰 전망입니다.
• 용도별로는 병원이 가장 높은 성장이 예상됩니다.
• 지역별로는 APAC이 예측 기간 동안 가장 높은 성장이 예상됩니다.

150페이지 이상의 종합적인 보고서를 통해 비즈니스 의사 결정에 도움이 되는 귀중한 인사이트를 제공합니다. 몇 가지 인사이트를 포함하는 샘플 다이어그램이 아래에 나와 있습니다.

통 마이 그래뉼 시장 새로운 동향

통 마이 그래뉼 시장은 미래와 세계의 보급 가능성을 결정하는 수많은 새로운 동향을 볼 수 있습니다.

• 과학적 검증의 중요성 : 큰 동향 중 하나는 통 마이 그래뉼(TMG)의 전통적인 용도를 증명하기 위해 높은 수준의 과학적 조사가 중요하다는 것입니다. 여기에는 활성 성분과 그 작용기전을 밝히는 약리학적 조사와 증거 기반 의료 기준에 따라 심혈관 질환의 치료에 효과를 입증하는 임상시험이 포함됩니다. 이 검증은 세계 의료 전문가에게 널리 받아 들여지기 위해 중요합니다.
• 고급 품질 관리 및 표준화 : TMG의 제조에 있어서는 고급 품질 관리 기법과 표준화가 점점 채용되고 있습니다. 여기에는 균일한 조성을 달성하고, 주요 바이오마커를 검출하고, 불순물을 제거하기 위한 고급 분석 방법의 사용이 포함됩니다. 표준화는 제품의 일관성을 보장하고 소비자와 의료 전문가의 신뢰를 얻는 데 매우 중요합니다.
• 통합 심장병학에 통합 : 새로운 방향성으로 TMG를 보완적인 치료법으로 통합 심장병학의 진료에 도입하는 것이 검토되고 있습니다. 이는 TMG를 전통적인 심혈관 치료와 병용함으로써 치료 효과를 증진시키고, 의약품의 부작용을 완화하며, 임상 증거를 뒷받침하는 환자의 전반적인 QOL을 향상시킬 수 있음을 의미합니다.
• 개선된 제형 및 전달 방법의 개발 : TMG는 과립이 전통적인 형태이지만, 더 나은 제형과 경우에 따라 새로운 전달 방법을 개발하려는 움직임이 있습니다. 여기에는 활성 성분의 생체이용률을 높이기 위한 추출 방법의 개선과 컴플라이언스 및 효능을 높이기 위해 환자에게 더 사용하기 쉬운 복용 형태가 포함됩니다.
• 세계의 규제 조화에 대한 대처 : 현재 진행 중이지만, 세계 각지에서 중의학과 한약의 규제 기준을 조화시키는 움직임이 점차 진행되고 있습니다. 이로 인해 안전과 품질의 일관된 요구 사항이 충족되면 구미 시장에 대한 통 마이 그래뉼 시장 진입이 쉬워질 수 있지만 여전히 많은 장벽이 존재합니다.

이러한 동향은 과학적 기반을 강화하고 제품의 품질과 균일성을 보장하고 기존의 건강 관리에 대한 통합을 촉진하고 편의성을 향상시키고 규제 개선을 통해 보다 광범위한 세계적 접근을 가능하게 하는 기초를 구축할 수 있어 통 마이 그래뉼 시장을 재정의하고 있습니다.

통 마이 그래뉼 시장 최근 동향

통 마이 그래뉼 시장은 신뢰성 향상과 심혈관 건강 관리 분야에서의 용도 확대에 중점을 둔 기술 혁신에 따라 변화하고 있습니다.

• 종합적인 약리학 연구 : 최근의 진보는 TMG의 개별 활성 성분을 인식하고 혈관 확장 및 항 염증 작용과 같은 심장혈관계에서 작용기전을 밝히는 광범위한 약리학 연구를 포함합니다.
• 추출·정제기술의 진보 : TMG를 구성하는 개별 허브로부터 보다 높은 수준의 생물활성화합물을 얻기 위해서 정제 및 추출에 있어서의 새로운 기술이 채용되어, 그 결과 보다 효과적이고 신뢰성이 높은 제제가 만들어지고 있습니다.
• 임상시험을 통한 효능 확인 : 협심증 및 관상동맥 질환과 같은 특정 심혈관 질환의 치료에서 TMG의 효능을 입증하기 위해, 일반적으로 엄격한 방법론에 따른 임상시험이 점점 더 많이 수행되고 있습니다.
• 보다 높은 품질 관리 기준 : TMG 제품의 안전성과 품질을 보장하기 위해 고급 분석 테스트 및 적절한 제조 기준(GMP)과 같은 엄격한 품질 관리 기준이 제조업체에서 채택되고 있습니다.
• 전통적 의약품과의 시너지 효과 연구 : TMG와 기존의 심혈관 치료제를 병용함으로써 환자의 예후를 개선하고 약물 투여량을 줄일 수 있을까 하는 시너지 효과의 가능성에 대한 조사가 시작되었습니다.

이러한 진보는 TMG의 응용에 대한 과학적 뒷받침을 강화하고, 제품의 품질을 향상시키고, 그 효능에 대한 임상적 증거를 만들어내고, 심혈관 질환의 통합 치료법에서 TMG의 위치를 조사함으로써 통 마이 그래뉼 시장에 영향을 미칩니다.

목차

제1장 주요 요약

제2장 세계의 통 마이 그래뉼 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• PESTLE 분석
• 특허 분석
• 규제 환경
• 업계의 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 통 마이 그래뉼 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 통 마이 그래뉼 시장 : 유형별
  • 무설탕 : 동향과 예측(2019-2031년)
  • 설탕 : 동향과 예측(2019-2031년)
• 세계의 통 마이 그래뉼 시장 : 용도별
  • 병원 : 동향과 예측(2019-2031년)
  • 클리닉 : 동향과 예측(2019-2031년)
  • 약국 : 동향과 예측(2019-2031년)
  • 기타 : 동향과 예측(2019-2031년)

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 통 마이 그래뉼 시장 : 지역별
• 북미의 통 마이 그래뉼 시장
• 유럽의 통 마이 그래뉼 시장
• 아시아태평양의 통 마이 그래뉼 시장
• 기타 지역의 통 마이 그래뉼 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간 경쟁 관계
  • 구매자의 협상력
  • 공급기업의 협상력
  • 대체품의 위협
  • 신규 참가업체의 위협

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 통 마이 그래뉼 시장 성장 기회 : 유형별
  • 세계의 통 마이 그래뉼 시장 성장 기회 : 용도별
  • 세계의 통 마이 그래뉼 시장 성장 기회 : 지역별
• 세계의 통 마이 그래뉼 시장 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 통 마이 그래뉼 시장 생산 능력 확대
  • 세계의 통 마이 그래뉼 시장 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 주요 기업의 기업 프로파일

• Xiuzheng Group
• Taiji Group
• Xuyang Pharm
• Ykpharm
• Sunflower Group
• Wansuiyaoye
• Shineway
• Henan Xingyuan Pharmaceutical
• Gansu Minhai Pharmaceutical
• Guizhou Bailing Group Pharmaceutical

영문목차

The future of the global tong mai granule market looks promising with opportunities in the hospital, clinic, and pharmacy markets. The global tong mai granule market is expected to grow with a CAGR of 8% from 2025 to 2031. The major drivers for this market are the rising awareness of tcm for cardiovascular health, the growing geriatric population with circulatory issues, and the increasing research highlighting benefits of key ingredients.

• Lucintel forecasts that, within the type category, sugary is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Tong Mai Granule Market

The tong mai granule market is seeing a number of emerging trends that are dictating its future and potential for greater global acceptance.

• Scientific Validation Emphasis: One major trend is the growing emphasis on scientific research of high standards to prove the traditional uses of TMG. This involves pharmacological research that determines active constituents and their modes of action, and clinical trials proving its efficacy in the treatment of cardiovascular diseases as per evidence-based medicine criteria. This validation is important for broader acceptance by medical professionals worldwide.
• Sophisticated Quality Control and Standardization: Advanced quality control practices and standardization are increasingly being adopted in the manufacturing of TMG. This includes the use of advanced analytical methods to achieve uniform composition, detect major biomarkers, and remove impurities. Standardization is critical for guaranteeing product consistency and trust among consumers and healthcare professionals.
• Integration into Integrative Cardiology: A new direction is the investigation of integrating TMG as a complementary treatment within integrative cardiology practices. This entails applying TMG in combination with traditional cardiovascular therapies to possibly augment therapeutic effects, decrease side effects of pharmaceutical medications, and enhance patients' overall quality of life, backed by clinical evidence.
• Development of Improved Formulations and Delivery Methods: While granules are the conventional form, there is a move towards creating better formulations and possibly new delivery methods for TMG. This may involve better extraction procedures to enhance bioavailability of active ingredients and more patient-friendly dosage forms to enhance compliance and efficacy.
• Global Harmonization Efforts for Regulation: There is an ongoing, but gradual, move towards increased harmonization of TCM and herbal medicine regulatory standards across various parts of the world. This has the potential to make TMG market entry into Western markets easier if consistent safety and quality requirements are met, though many barriers still exist.

These trends are redefining the tong mai granule market by solidifying its scientific foundation, guaranteeing product quality and uniformity, facilitating its integration into conventional healthcare, enhancing its convenience, and potentially laying the groundwork for broader global accessibility through regulatory improvements.

Recent Developments in the Tong Mai Granule Market

The market for tong mai granule is changing with innovations focused on its credibility improvement and widening its usage in cardiovascular wellness management.

• Comprehensive Pharmacological Researches: Recent advances comprise extensive pharmacological studies that recognize the individual active constituents of TMG and delineate their mechanism of action in the cardiovascular system, including vasodilation and anti-inflammatory action.
• Technology Advances in Extraction and Purification: Emerging technologies in purification and extraction are being adopted to achieve higher levels of bioactive compounds from the individual herbs that constitute TMG, resulting in more effective and reliable formulations.
• Clinical Trials Confirming Efficacy: More and more clinical trials, usually following strict methodologies, are being undertaken to establish evidence for TMG's efficacy in the treatment of certain cardiovascular diseases such as angina pectoris and coronary artery disease.
• Higher Quality Control Standards: More rigorous quality control standards, such as sophisticated analytical testing and Good Manufacturing Practices (GMP), are being adopted by manufacturers to guarantee the safety and quality of TMG products.
• Investigation of Synergistic Effects with Traditional Drugs: Research is starting to investigate the possible synergistic effects of combining TMG with traditional cardiovascular drugs in order to enhance patient outcomes and possibly lower drug dosages.

These advances are influencing the tong mai granule market by lending more scientific support for its application, providing improved product quality, generating clinical evidence of its efficacy, and investigating its place in integrative treatment methods for cardiovascular illnesses.

Strategic Growth Opportunities in the Tong Mai Granule Market

The tong mai granule market presents several strategic growth opportunities by leveraging its traditional use in cardiovascular health and emerging scientific validation.

• Adjunctive Therapy in Coronary Artery Disease: A key opportunity for growth exists in marketing TMG as an adjunctive treatment to standard treatments for coronary artery disease to increase blood flow, alleviate symptoms of angina, and improve general cardiac function.
• Peripheral Vascular Disease Management: Leveraging the circulatory-enhancing actions of TMG presents a growth opportunity in managing peripheral vascular disease to relieve symptoms such as claudication and enhance limb perfusion.
• Post-Stroke Rehabilitation Support: Increasing scope exists to investigate the application of TMG in post-stroke rehabilitation to support recovery of neurological function and enhance blood flow to the brain.
• Preventive Cardiovascular Health: Framing TMG as a preventive approach for patients at risk of developing cardiovascular disease, including hypertension or hyperlipidemia, represents a large growth opportunity in the wellness market.
• Integrative Treatment of Angina Pectoris: Adding TMG as an integrative part of the treatment regimen for angina pectoris, combined with lifestyle change and conventional therapy, represents an opportunity for growth through reduced incidence and severity of chest pain.

These growth strategies point to the opportunity for the tong mai granule market to increase its contribution to cardiovascular medicine by delivering complementary and possibly preventative therapies to various conditions.

Tong Mai Granule Market Driver and Challenges

The tong mai granule market is driven by the rising global incidence of cardiovascular diseases and increasing interest in traditional medicine, and challenged by scientific validation and regulatory acceptance.

The factors responsible for driving the tong mai granule market include:

1. Increasing Incidence of Cardiovascular Diseases: The growing worldwide prevalence of cardiovascular diseases, including coronary artery disease and stroke, creates the need for effective treatments and supportive therapies such as TMG.

2. Increasing Interest in Traditional Chinese Medicine: The growing global interest and acceptability of TCM as an adjunct therapeutic system fuel the demand for TCM formulations such as TMG for different health disorders.

3. Emerging Clinical Evidence: Growing clinical evidence indicating the possible benefits of TMG in enhancing blood flow and treating cardiovascular symptoms serves as a driving force for its market expansion.

4. Demand for Natural and Plant-Based Remedies: The overall consumer trend towards natural and plant-based healthcare solutions favors the use of herbal products such as TMG.

5. Government Support in China: Strong government support of the TCM industry in China, in the form of research efforts and inclusion in the healthcare system, is a strong impetus behind the TMG market in China.

Challenges in the tong mai granule market are:

1. Requirement of More Effective Clinical Trials: A major challenge lies in the need for more high-quality large-scale clinical trials according to international standards to confirm beyond doubt the effectiveness of TMG for a certain cardiovascular disorder.

2. Western market Regulatory Barriers: Securing regulatory clearance and broader acceptance in Western nations such as the United States and Germany is an important issue owing to high standards for efficacy and safety evidence of herbal medications.

3. Quality Control Uniformity and Standardization: Maintaining uniform quality and standardized form of TMG, considering the natural variability among herbal ingredients, is an issue for international market penetration and acceptance by medical professionals.

In short, the tong mai granule market is propelled by the rising incidence of cardiovascular disease, interest in TCM, and new clinical data. Yet to achieve future growth and greater acceptance, overcoming issues regarding the necessity of more stringent clinical trials, overcoming regulatory challenges in Western markets, and maintaining consistent standardization and quality control are essential.

List of Tong Mai Granule Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies tong mai granule companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the tong mai granule companies profiled in this report include-

• Xiuzheng Group
• Taiji Group
• Xuyang Pharm
• Ykpharm
• Sunflower Group
• Wansuiyaoye
• Shineway
• Henan Xingyuan Pharmaceutical
• Gansu Minhai Pharmaceutical
• Guizhou Bailing Group Pharmaceutical

Tong Mai Granule Market by Segment

The study includes a forecast for the global tong mai granule market by type, application, and region.

Tong Mai Granule Market by Type [Value from 2019 to 2031]:

• Sugar Free
• Sugary

Tong Mai Granule Market by Application [Value from 2019 to 2031]:

• Hospital
• Clinic
• Pharmacy
• Others

Tong Mai Granule Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Tong Mai Granule Market

The market for the tong mai granule is mainly based on Traditional Chinese Medicine (TCM) and targets preparations to enhance blood circulation and cardiovascular diseases. The usual composition includes herbs such as Salvia miltiorrhiza, Logistical chuanxiong, and Pueraria lobata, which is applied for angina and stroke. The recent advances are indicative of an international trend toward applying traditional medicine to scientific proof. This encompasses initiatives aimed at standardizing manufacturing, conducting clinical trials, and coping with various regulatory regimes in strategic markets such as the United States, China, Germany, India, and Japan that affect its availability and acceptance.

• United States: The US market for TMG remains quite small, with access primarily via specialized TCM practitioners and the internet. Recent trends include limited research interest in the cardiovascular action of TMG ingredients. Regulatory barriers to TCM products by the FDA limit extensive use and adaptation into mainstream medicine. Emphasis is placed on the elaboration of pharmacological mechanisms via basic science studies.
• China: Being the home of TCM, China is the major market for TMG. The recent advances are in large-scale production, strict quality control standards, and extensive clinical trials to prove its efficacy in the treatment of a variety of cardiovascular disorders. Government backing for the TCM industry helps it gain extensive use in the healthcare system and continued research.
• Germany: The German TCM market, including TMG, is expanding because of heightened public demand for traditional remedies. Developments include intensified monitoring of the quality and performance of TCM products under EU standards. Joint studies between German and Chinese research institutions seek to confirm the advantages of TMG, yet access to the market demands compliance with rigorous European standards for safety and quality.
• India: India, which also has its own Ayurvedic tradition of medicine, has a smaller but expanding market for TCM products such as TMG. Recent events have included growing awareness and early regulatory moves toward quality control of imported TCM products. Research centers on understanding the ways in which TMG's action conforms to or diverges from Indian traditional cardiovascular medicines.
• Japan: In Japan, Campo medicine, which has historical origins similar to TCM, has an established position in healthcare. The TMG market is present but not widespread. Recent trends include continued research into the particular impact of TMG ingredients on blood flow and cardiovascular well-being in the Japanese context.

Features of the Global Tong Mai Granule Market

• Market Size Estimates: Tong mai granule market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Tong mai granule market size by type, application, and region in terms of value ($B).
• Regional Analysis: Tong mai granule market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the tong mai granule market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the tong mai granule market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the tong mai granule market by type (sugar free and sugary), application (hospital, clinic, pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Tong Mai Granule Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: PESTLE Analysis
• 2.4: Patent Analysis
• 2.5: Regulatory Environment
• 2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Tong Mai Granule Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Tong Mai Granule Market by Type
  • 3.3.1: Sugar Free: Trends and Forecast (2019 to 2031)
  • 3.3.2: Sugary: Trends and Forecast (2019 to 2031)
• 3.4: Global Tong Mai Granule Market by Application
  • 3.4.1: Hospital: Trends and Forecast (2019 to 2031)
  • 3.4.2: Clinic: Trends and Forecast (2019 to 2031)
  • 3.4.3: Pharmacy: Trends and Forecast (2019 to 2031)
  • 3.4.4: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Tong Mai Granule Market by Region
• 4.2: North American Tong Mai Granule Market
  • 4.2.1: North American Market by Type: Sugar Free and Sugary
  • 4.2.2: North American Market by Application: Hospital, Clinic, Pharmacy, and Others
  • 4.2.3: The United States Tong Mai Granule Market
  • 4.2.4: Mexican Tong Mai Granule Market
  • 4.2.5: Canadian Tong Mai Granule Market
• 4.3: European Tong Mai Granule Market
  • 4.3.1: European Market by Type: Sugar Free and Sugary
  • 4.3.2: European Market by Application: Hospital, Clinic, Pharmacy, and Others
  • 4.3.3: German Tong Mai Granule Market
  • 4.3.4: French Tong Mai Granule Market
  • 4.3.5: Spanish Tong Mai Granule Market
  • 4.3.6: Italian Tong Mai Granule Market
  • 4.3.7: The United Kingdom Tong Mai Granule Market
• 4.4: APAC Tong Mai Granule Market
  • 4.4.1: APAC Market by Type: Sugar Free and Sugary
  • 4.4.2: APAC Market by Application: Hospital, Clinic, Pharmacy, and Others
  • 4.4.3: Japanese Tong Mai Granule Market
  • 4.4.4: Indian Tong Mai Granule Market
  • 4.4.5: Chinese Tong Mai Granule Market
  • 4.4.6: South Korean Tong Mai Granule Market
  • 4.4.7: Indonesian Tong Mai Granule Market
• 4.5: ROW Tong Mai Granule Market
  • 4.5.1: ROW Market by Type: Sugar Free and Sugary
  • 4.5.2: ROW Market by Application: Hospital, Clinic, Pharmacy, and Others
  • 4.5.3: Middle Eastern Tong Mai Granule Market
  • 4.5.4: South American Tong Mai Granule Market
  • 4.5.5: African Tong Mai Granule Market

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Tong Mai Granule Market by Type
  • 6.1.2: Growth Opportunities for the Global Tong Mai Granule Market by Application
  • 6.1.3: Growth Opportunities for the Global Tong Mai Granule Market by Region
• 6.2: Emerging Trends in the Global Tong Mai Granule Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Tong Mai Granule Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Tong Mai Granule Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Xiuzheng Group
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.2: Taiji Group
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.3: Xuyang Pharm
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.4: Ykpharm
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.5: Sunflower Group
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.6: Wansuiyaoye
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.7: Shineway
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.8: Henan Xingyuan Pharmaceutical
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.9: Gansu Minhai Pharmaceutical
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.10: Guizhou Bailing Group Pharmaceutical
  • Company Overview
  • Tong Mai Granule Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing